skip to Main Content

2022 Women's Venture Competition

The AIM-HI Accelerator Fund congratulates our women scientist-entrepreneur finalists and semi-finalists and their companies of the 2022 Women’s Venture Competition. The program, now in its third year, provides funding, coaching and networking opportunities to women-led oncology start-ups aimed to address unmet medical needs and compete for seed stage funding and prizes.

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Semi-Finalists

Selma-Durmo

Selma Durmo, M.Pharma
CEO

Bodour-Salhia

Bodour Salhia, Ph.D.
Founder & CEO

CpG-Diagnostics
Revital Mandil-Levin

Revital Mandil Levin, Ph.D.
Founder & CEO

Nanocarry-Tx
Zeenia-Kaul

Zeenia Kaul, Ph.D.
Co-Founder, CEO &  CSO

Reheva-Biosciences
Johanna-Webb

Johanna Webb
President

RiverWalk-Tx
Rosa-Hwang

Rosa Hwang, M.D.
Co-Founder

Stellanova-Tx

The AIM-HI Accelerator Fund congratulates our 10 women scientist-entrepreneur semi-finalists and their companies of the 2021 Women’s Venture Competition. The winning company of 2021 Women’s Venture Competition will receive a total of $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation. which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

In addition, the AIM-HI Women’s Venture Competition is looking to name one of our semi-finalists as the People’s Choice Award for Best Pitch. Who will it be? We can’t all be on the official Judging Committee for the Women’s Venture Competition …  but we can ALL Cast our Vote! 

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Back To Top